Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
Tom G. Caniels, Ilja Bontjer, Karlijn van der Straten, Meliawati Poniman, Judith A. Burger, Brent Appelman, Ayesha H.A. Lavell, Melissa Oomen, Gert-Jan Godeke, Coralie Valle, Ramona Mögling, Hugo D.G. van Willigen, Elke Wynberg, Michiel Schinkel, Lonneke A. van Vught, Denise Guerra, Jonne L. Snitselaar, Devidas N. Chaturbhuj, Isabel Cuella Martin, Amsterdam UMC COVID-19 S3/HCW study group, John P. Moore, Menno D. de Jong, Chantal Reusken, Jonne J. Sikkens, Marije K. Bomers, Godelieve J. de Bree, Marit J. van Gils, Dirk Eggink, Rogier W. Sanders
doi: https://doi.org/10.1101/2021.05.26.21257441
Tom G. Caniels
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Ilja Bontjer
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Karlijn van der Straten
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Meliawati Poniman
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Judith A. Burger
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Brent Appelman
2Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Ayesha H.A. Lavell
3Department of Internal Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Melissa Oomen
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Gert-Jan Godeke
4Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
Coralie Valle
4Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
Ramona Mögling
4Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
Hugo D.G. van Willigen
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Elke Wynberg
5Department of Infectious Diseases, Public Health Service of Amsterdam, GGD, Amsterdam, the Netherlands
Michiel Schinkel
2Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Lonneke A. van Vught
2Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Denise Guerra
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Jonne L. Snitselaar
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Devidas N. Chaturbhuj
6Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, USA
Isabel Cuella Martin
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
John P. Moore
6Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, USA
Menno D. de Jong
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Chantal Reusken
4Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
Jonne J. Sikkens
3Department of Internal Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Marije K. Bomers
3Department of Internal Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Godelieve J. de Bree
7Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Marit J. van Gils
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Dirk Eggink
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
4Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
Rogier W. Sanders
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
6Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, USA
Data Availability
All data are available in the main text or the supplementary materials. Reagents used in this study are available upon reasonable request under an MTA with Amsterdam UMC.
Posted June 01, 2021.
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
Tom G. Caniels, Ilja Bontjer, Karlijn van der Straten, Meliawati Poniman, Judith A. Burger, Brent Appelman, Ayesha H.A. Lavell, Melissa Oomen, Gert-Jan Godeke, Coralie Valle, Ramona Mögling, Hugo D.G. van Willigen, Elke Wynberg, Michiel Schinkel, Lonneke A. van Vught, Denise Guerra, Jonne L. Snitselaar, Devidas N. Chaturbhuj, Isabel Cuella Martin, Amsterdam UMC COVID-19 S3/HCW study group, John P. Moore, Menno D. de Jong, Chantal Reusken, Jonne J. Sikkens, Marije K. Bomers, Godelieve J. de Bree, Marit J. van Gils, Dirk Eggink, Rogier W. Sanders
medRxiv 2021.05.26.21257441; doi: https://doi.org/10.1101/2021.05.26.21257441
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
Tom G. Caniels, Ilja Bontjer, Karlijn van der Straten, Meliawati Poniman, Judith A. Burger, Brent Appelman, Ayesha H.A. Lavell, Melissa Oomen, Gert-Jan Godeke, Coralie Valle, Ramona Mögling, Hugo D.G. van Willigen, Elke Wynberg, Michiel Schinkel, Lonneke A. van Vught, Denise Guerra, Jonne L. Snitselaar, Devidas N. Chaturbhuj, Isabel Cuella Martin, Amsterdam UMC COVID-19 S3/HCW study group, John P. Moore, Menno D. de Jong, Chantal Reusken, Jonne J. Sikkens, Marije K. Bomers, Godelieve J. de Bree, Marit J. van Gils, Dirk Eggink, Rogier W. Sanders
medRxiv 2021.05.26.21257441; doi: https://doi.org/10.1101/2021.05.26.21257441
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)